Related Experiment Video
Updated: Jan 28, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Low MiR-149 expression is associated with unfavorable prognosis and enhanced Akt/mTOR signaling in glioma
Liang Xue1, Yi Wang1, Shuyuan Yue1
1Department of Neurosurgery, Tianjin Medical University General Hospital Tianjin 300052, P. R. China.
Abstract:
MicroRNAs (miRs) play critical roles in the progression of glioma. Previous in vitro studies have described the anti-tumor role of miR-149 in cancer cells including glioma. In this study, we aimed to investigate whether miR-149 is associated with the prognosis of glioma patients. A total of 163 glioma patients who underwent tumor resection were included in our follow-up study. We found that the miR-149 expression was significantly lower in tumor tissues compared with that in normal tissues (P<0.05). Kaplan-Meier and analysis showed that the miR-149 expression status was significantly associated with the survival duration (logrank test, P<0.001), and multivariate Cox regression revealed that patients with low miR-149 expression were exposed to a 1.825 fold higher death risk (HR=1.825, 95% CI=1.031-3.229, P=0.039) compared with those with high miR-149 expression. Further study showed that Akt/mTOR signaling was hyperactive in low miR-149 expressing tissues. Our study thus demonstrates that miR-149 expression in glioma tissues is critically associated with the prognosis of patients, suggesting its potential clinical significance.
Insights
Low miR-149 expression in glioma tumors is linked to poorer patient survival. This microRNA (miRNA) may serve as a prognostic biomarker for glioma, potentially impacting treatment strategies.
Area of Science:
- Neuro-oncology
- Molecular Biology
- Genetics
Background:
- MicroRNAs (miRNAs) are crucial regulators in glioma development.
- Previous research indicated miR-149 has anti-tumor properties in glioma cell lines.
Purpose of the Study:
- To determine the association between miR-149 expression and glioma patient prognosis.
- To investigate the clinical significance of miR-149 in glioma.
Main Methods:
- Analysis of miR-149 expression in tumor and normal tissues from 163 glioma patients.
- Kaplan-Meier survival analysis and multivariate Cox regression were employed.
- Investigation of Akt/mTOR signaling pathway activity in relation to miR-149 levels.
Main Results:
- miR-149 expression was significantly lower in glioma tissues compared to normal tissues.
- Low miR-149 expression correlated with shorter survival duration (logrank test, P<0.001).
- Patients with low miR-149 had a 1.825-fold increased risk of death (HR=1.825, P=0.039), with hyperactive Akt/mTOR signaling observed.
Conclusions:
- Glioma miR-149 expression is significantly associated with patient prognosis.
- miR-149 may serve as a potential prognostic biomarker for glioma.
- Aberrant Akt/mTOR signaling is linked to reduced miR-149 expression in glioma.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
What is Cell Signaling?
Bacterial Signaling
Self-Evaluation: Self-Enhancement and Self-Verification
Intracellular Signaling Cascades

